MINNEAPOLIS, Dec. 16, 2024
After securing an additional $19 million in funding led by Epic Venture Partners, FastWave Medical is set to advance its pipeline of next-generation IVL platforms.
Advertisement
MINNEAPOLIS, Dec. 16, 2024 /PRNewswire-PRWeb/ -- FastWave Medical, a clinical-stage medical device company, announced the close of an oversubscribed $19 million funding round earlier this year, increasing the total capital invested into the company to over $40 million. This significant investment, led by Epic Venture Partners with participation from M&L Healthcare Investments and the company's existing investors, will fuel FastWave's rapid development momentum and provide crucial support for ongoing regulatory and clinical initiatives of its portfolio of IVL platforms.
Advertisement
FastWave Medical co-founder and CEO Scott Nelson expressed the team's excitement, "We are beyond thrilled to partner with physician-led investors like Epic and M&L who see the clinical promise and commercial viability of both our IVL systems. This round of stage-appropriate funding is a testament to the confidence the market has in our approach and takes us one step closer to our goal of empowering interventionalists across the world with next-level IVL therapies."
Since its formation in 2021, FastWave has been swiftly moving in its efforts to tackle the challenges of artery calcification with advanced intravascular lithotripsy (IVL) solutions. As the global population ages, the demand for effective, minimally invasive treatments is escalating. FastWave's commitment to providing physicians with highly deliverable IVL catheters that offer durable, 360-degree sonic output has led to the rapid development of a pipeline of IVL systems that hold the potential to positively impact patient care.
"On every metric, FastWave's pace of innovation stands out," said Bryan Edelstein, Managing Partner of Epic Venture Partners. "We are excited to be a part of helping FastWave build on their impressive cadence to reach the company's next key clinical and regulatory initiatives."
Dr. Arthur Lee, interventional cardiologist and Managing Partner of Epic Venture Partners, added, "FastWave is moving quickly and decisively to become best-in-class in the IVL space. We are excited to support the FastWave team, as they continue to take down milestone after milestone in their mission to save lives and offer this groundbreaking technology to all who need it."
Dr. Steven Kum, vascular surgeon and Chief Medical Officer of M&L Healthcare Investments, holds similar optimism, "FastWave Medical has all the hallmarks of a company poised for significant growth and impact. Their commitment to evidence-based development aligns perfectly with our investment philosophy, and we're excited to be a part of a new era of IVL innovation that addresses the gaps left by current technologies."
About FastWave Medical Inc.
FastWave Medical is at the forefront of developing intravascular lithotripsy (IVL) systems for calcific artery disease. With a focus on empowering physicians with procedural efficiency, FastWave aspires to redefine the sector by introducing next-generation IVL technologies that elevate the clinician experience and overall patient care. For more insights, please visit https://fastwavemedical.com.
About Epic Venture Partners
Epic Venture Partners is democratizing venture capital by offering high-net-worth individuals exclusive access to investment opportunities in companies with groundbreaking technologies. To learn more, visit https://epicventurepartners.com.
About M&L Healthcare
Under the leadership of Executive Director Ms. Jocelyn Kum and Chief Medical Officer Dr. Steven Kum, M&L Healthcare Investments, a subsidiary of the diversified M&L Group valued at approximately $2.5 billion, is making strategic investments across various sectors. Leveraging the group's extensive international network and robust investment acumen, M&L Healthcare is well-positioned for significant growth. To learn more, visit https://mnlhealthcare.com.
Media Contact
FastWave Medical
(833) 888-9283
[email protected]
Media Contact
Media Relations, FastWave Medical, 1 (833) 888-9283, [email protected], https://fastwavemedical.com
View original content to download multimedia:https://www.prweb.com/releases/fastwave-medical-announces-oversubscribed-19m-fundraise-accelerating-the-future-of-its-ivl-systems-for-cardiovascular-calcium-treatment-302324562.html
SOURCE FastWave Medical
